PubMed COVID-19 Clinical Care

CONCLUSION: Among non-hospitalized patients with at least one risk factor for progression to severe COVID-19, a 3-day course of intravenous remdesivir yielded favourable results.

This retrospective analysis describes the administration of sotrovimab in 32 children (22 aged 12 to 16 years old; 10 aged 1-11 years old) who were at high risk of deterioration to severe COVID-19 disease. We provide dosing suggestions and

No abstract

The pandemic of COVID-19 is undoubtedly one of the biggest challenges for modern healthcare. In order to analyze the spatio-temporal aspects of the spread of COVID-19, technology has helped us to track, identify and store information regarding

In addition to being the primary target of infections such as viral hepatitis, the liver may also be affected by systemic disease. These include bacterial, mycotic, and viral infections, as well as autoimmune and infiltrative diseases. These

CONCLUSION: In conclusion, our study demonstrated the role of the innate immune response in the regulation of endothelial dysfunction in both KD and COVID-19. Additionally, our findings indicate that the adaptive immunity activation differs between

No abstract

Policy makers aim to respect public preferences when making trade-offs between policies, yet most estimates of the value of safety neglect individuals' preferences over how safety is distributed. Incorporating these preferences into policy first

CONCLUSIONS: Few evaluations rigorously evaluated the effect of health systems interventions on improving health services and outcomes. Results will inform upscaling successful intervention components, and strategies to mitigate the effect of COVID

CONCLUSIONS: Psychosocial concerns are highly prevalent amongst children and adolescents during the COVID-19 pandemic. Based on identified needs of this cohort, additional community health supports are required, particularly for higher risk groups.